Diffuse Leptomeningeal Glioneural Tumours (DLGT)

Diffuse leptomeningeal glioneural tumours (DLGT), also known as diffuse leptomeningeal neuroepithelial tumour or primary leptomeningeal oligodendrogliomatosis, are a rare type of central nervous system (CNS) tumour that generally develops from leptomeninges. Meninges are the layers of tissue that cover the brain and the spinal cord in the CNS, and include the leptomeninges (the inner most layer of meninges). DLGTs are classified as glioneural tumours, as they contain both glial cells (supportive cells within the central nervous system) and nerve cells/neuronal cells (receive sensory input from internal and external stimuli, and relay information to the brain).

The brain is a complex organ that is responsible for controlling all functions of the body. It has five main portions: the cerebrum, cerebellum, brainstem, pituitary gland, and hypothalamus. The cerebrum is the biggest part of the brain, and consists of the frontal, parietal, temporal, and occipital lobes. This part of the brain is responsible for voluntary movement, intelligence, and memory. The cerebellum is a small part of the brain located at the back of the head, and regulates posture and balance. The brainstem is a small, stalk-like structure towards the bottom of the brain that connects the brain to the spinal cord.  It regulates many vital bodily processes, such as swallowing, breathing, and heart rate. The pituitary gland is a pea sized organ located behind the eyes, and is responsible for the production and secretion of hormones in the body. The hypothalamus is located deep within the brain and has many important functions, such as producing and secreting different hormones, regulating temperature and controlling appetite.

The spinal cord is a long, thin, tubular structure that extends down from the brainstem to the lower back. It is made of nerve tissue and is surrounded by the bones of the spine (vertebrae). The spinal cord is responsible for transmitting nerve signals from the brain to the body and vice versa. It has motor functions (such as voluntary movement), sensory functions (such as pressure, touch, temperature, and pain), and autonomous functions (such as regulating digestion, heart rate, and blood pressure).

DGLTs are generally considered to be slow-growing and benign tumours. They most commonly affect the spinal cord, posterior fossa (a small piece of the skull near the brainstem), brainstem, and base of the brain, however they can develop in other areas of the CNS as well. DGLTs are termed ‘diffuse’, as these tumours are not well contained.

DLGTs are generally more common in males, and tend to affect children between the ages of 5-14. However, anyone can develop this disease.

Treatment

When cancers are detected, they are staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you. However, as most DLGTs are considered benign, these tumours are generally considered low-grade and are not staged.

Once your tumour has been diagnosed, your doctor may recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.

Treatment is dependent on several factors, including location, age, stage of disease and overall health.

Treatment options for DLGTs may include:

  • Surgery to remove as much of the tumour as possible.
  • Shunt insertion.
  • Chemotherapy.
  • Radiation therapy.
  • Targeted therapy.
  • Clinical trials.
  • Palliative care.

Risk factors

Because of how rare DLGTs are, there has been limited research done into the risk factors of this disease.

Symptoms

Symptoms of DLGTs may include:

  • Hydrocephalus, which caries its own set of symptoms:
    • Headaches.
    • Nausea and/or vomiting.
    • Difficulties with eye movement.
    • Difficulties with balance.
    • Difficulties walking.
  • Muscle spasms.
  • Nerve irritation, which carries its own set of symptoms:
    • Numbness and/or decreased sensation in affected area.
    • Sharp aching or burning pain, which often radiates outwards from affected area.
    • Tingling/pins and needles in affected area.
    • Muscle weakness in affected area.
  • Eye sensitivity to bright light.
  • Neck stiffness.
  • Seizures (rare).
  • Poor muscle control.
  • Spinal cord compression.
  • Fatigue.

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

If your doctor suspects you have an DLGT, they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment:

  • Physical examination.
  • Neurological examination.
  • Imaging tests, most commonly a MRI (magnetic resonance imaging).
  • Biopsy.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.